Fig. 3 | Scientific Reports

Fig. 3

From: Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma

Fig. 3

Effects of QR-KLU on the apoptosis and cell cycle of liver cancer cells (n = 6). (A) Effects of QR, KLU, and QR-KLU on the apoptosis of Hepa1–6 cells under normoxic and hypoxic conditions. Hypoxic condition was created by adding 100 µM cobalt dichloride. (B) Effects of QR, KLU, and QR-KLU on the cell cycle of Hepa1–6 cells. QR-KLU peptide (QR)–drug (KLU) conjugate.

Back to article page